Business Context and Reporting Period
UY Scuti Acquisition Corp. (UYSC), a Cayman Islands-based special purpose acquisition company (SPAC), filed this Form 8-K on April 6, 2026, reporting events occurring on March 31, 2026. The filing details the results of an Extraordinary General Meeting where shareholders approved amendments to extend the deadline for consummating a business combination.
Key Financial Metrics and Capital Structure
- Extension Funding: The Sponsor's designee deposited $450,000 into the Trust Account to fund the first three-month extension period.
- Shareholder Redemptions: 2,437,288 ordinary shares were redeemed at approximately $10.38 per share, totaling approximately $25.3 million in cash outflow from the trust.
- Debt Obligations:
- Sponsor Promissory Note: The maturity date of an unsecured promissory note (up to $1,000,000 principal) was extended from March 31, 2026, to March 31, 2027. The note bears no interest and is convertible into units at $10.00 per unit.
- Extension Payment Loan: A new loan of $450,000 was secured from Sun Peisha (Sponsor designee) to fund the extension fee. This amount is anticipated to be convertible into securities upon a business combination.
- Liquidity: The filing does not provide specific cash balances outside the Trust Account or detailed liquidity metrics beyond the extension deposit.
Material Changes Versus Prior Period
- Extension of Termination Date: The deadline to complete a business combination was extended from April 1, 2026, to April 1, 2027. The company now has the ability to extend this date up to four times in total (12 months cumulative) from the original date.
- Extension Fee Adjustment: The required deposit for each three-month extension period was reduced from $575,000 to $450,000.
- Trust Account Restrictions: Amendments were approved prohibiting the withdrawal of interest from the Trust Account to pay dissolution expenses.
- Leadership Change: Ms. Jiawen Zhao, previously Chief Investment Officer, was appointed Interim Chief Financial Officer effective April 5, 2026.
Guidance, Outlook, and Risks
- Outlook: Management intends to utilize the extended timeline to consummate a business combination. The company will not seek another shareholder vote for further extensions within the approved framework.
- Risks and Contingencies:
- Liquidation Trigger: If the revised extension fee ($450,000) is not deposited timely, the company has a 30-day cure period. Failure to pay within this period will result in the prompt liquidation of the Trust Account and distribution to public shareholders.
- Redemption Risk: Significant redemptions (approx. 27% of shares present at the meeting) reduced the capital available in the trust, though the extension fee was successfully funded.
- Unusual Items: The filing notes the issuance of a convertible note for the extension loan is anticipated but not yet filed as an exhibit at the time of this report.
Investor Verification Checklist
- Verify the exact number of shares outstanding post-redemption to assess the remaining trust value per share.
- Confirm the execution and terms of the convertible note for the $450,000 extension loan once filed.
- Monitor the company's progress toward a business combination within the new April 1, 2027, deadline.
- Review the financial impact of the $450,000 extension fee on the company's working capital outside the trust.
- Assess the experience and track record of the new Interim CFO, Ms. Jiawen Zhao, in managing SPAC liquidations or combinations.